Search Within

David R Spriggs

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (20)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (72)
  2. Biostatistics Service (68)
  3. Department of Medicine (62)
  4. Solid Tumor Oncology Division (62)
  5. Gynecology Disease Management Team (51)
  6. GDMT, Medicine (49)

More Groups

People
  1. Alexia Iasonos (42)
  2. Carol Aghajanian (42)
  3. Paul Sabbatini (36)
  4. Martee Hensley (29)
  5. Venkatraman Seshan (24)
  6. David Hyman (21)

More People

Years
  1. 2022 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (4)
  5. 2015 (7)
  6. 2014 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Gynecologic Oncology (15)
  3. Clinical Cancer Research (8)
  4. International Journal of Gynecological Cancer (5)
  5. Cancer (4)
  6. Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (16)
  3. Elsevier Inc. (15)
  4. Lippincott Williams & Wilkins (6)
  5. Wiley Blackwell (4)
  6. Oxford University Press (2)

More Publishers

Results (72)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers
    Journal Article

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Iasonos, A.; Kauff, N. D.; Spriggs, D.
    Gynecologic Oncology (2011)

    Fulltext@MSK | Save
  • Defining clinical and statistical improvement in consolidation single-arm trials in ovarian cancer
    Meeting Abstract

    Spriggs, D. R.; Iasonos, A.; Sabbatini, P.; O'Cearbhaill, R. E.; Thaler, H. T.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • CA125 response to bevacizumab in recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Zhou, Q.; Iasonos, A.; Diaz, J. P.; Tew, W. P.; Hensley, M. L.; O'Flaherty, C.; Aghajanian, C.; Spriggs, D. R.; Sabbatini, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dual fluorescence high throughput screen detects MUC16 selective therapeutic candidates
    Meeting Abstract

    Thapi, D.; Normand, G.; Ivnitski Steele, I. D.; Ostrovnaya, I.; Shum, D.; Spriggs, D. R.; Djaballah, H.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Consolidation strategies in ovarian cancer: Observations for future clinical trials
    Journal Article

    Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Hensley, M.; Tew, W.; Konner, J.; Bell-Mcguinn, K.; Juretzka, M.; Iasonos, A.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment
    Journal Article

    O'cearbhaill, R.; Zhou, Q.; Iasonos, A.; Hensley, M. L.; Tew, W. P.; Aghajanian, C.; Spriggs, D. R.; Lichtman, S. M.; Sabbatini, P. J.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16
    Journal Article

    Dharma Rao, T.; Park, K. J.; Smith-Jones, P.; Iasonos, A.; Linkov, I.; Soslow, R. A.; Spriggs, D. R.
    Applied Immunohistochemistry & Molecular Morphology (2010)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies
    Journal Article

    Iasonos, A.; Wilton, A. S.; Riedel, E. R.; Seshan, V. E.; Spriggs, D. R.
    Clinical Trials (2008)

    Fulltext@MSK | Save
  • Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
    Journal Article

    Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save